Pregnancy-Specific Anxiety Tool (PSAT)
The Journal of Clinical Psychiatry · 19.04.2023 · 84 (3)
DOI: 10.4088/jcp.22m14696 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Psychiatry, online erschienen am 19.04.2023. Verfasst von Hamideh Bayrampour und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Practice, University of British Columbia (UBC), Vancouver, Canada. Hauptthemen laut MEDLINE: Anxiety, Anxiety Disorders. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Gefördert von: CIHR.
Abstract (Originalsprache)
Objective
Pregnancy-specific anxiety (PSA) is a distinct construct from general anxiety and depression. The purpose of this study was to develop, evaluate, and validate the Pregnancy-Specific Anxiety Tool (PSAT), to measure PSA and its severity.
Methods
The study was carried out in 2 stages. Stage 1 involved item development and content and face validation. Stage 2 included psychometric evaluation to examine item distributions and correlational structure, dimensionality, internal consistency reliability, stability, and construct, convergent, and criterion validity, using 2 independent samples (initial sample N = 494, May-October 2018; validation sample N = 325, July 2019-May 2020).
Results
Eighty-two items were evaluated for face validity and 41 items were considered in stage 2 based on feedback from participants and experts. Model fit from exploratory factor analysis and patterns of item-factor loadings suggested a 6-factor model with 33 items. The 6 factors included items pertaining to health and well-being of the baby, labor and the pregnant person's well-being, postpartum, support, career and finance, and indicators of severity. Confirmatory factor analysis carried out using the initial sample showed good fit with the validation sample. The area under the curve (AUC) for the diagnosis of adjustment disorders (AD) was 0.73 (95% CI, 0.67-0.79), and for AD/any anxiety disorders, the AUC was 0.80 (95% CI, 0.75-0.85).
Conclusions
The PSAT can be useful for screening and monitoring of PSA, and pregnant people with scores higher than 10 should be considered for further assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Family Practice, University of British Columbia (UBC), Vancouver, Canada.
- Corresponding author: Hamideh Bayrampour, MSc, PhD, Department of Family Practice, 320 - 5950 University Blvd, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada (hamideh.bayrampour@ubc.ca).
- Department of Psychology, Simon Fraser University, Vancouver, Canada.
- Department of Pediatrics, University of British Columbia (UBC), Vancouver, Canada.
- School of Nursing, Trinity Western University, Langley, Canada.
- Centre for Health Evaluation and Outcome Science, Providence Health Care, Vancouver, Canada.
Förderung
- CIHR
Zitieren
APA
Bayrampour, H., Hohn, R. E., Tamana, S. K., Sawatzky, R., Janssen, P. A., Bone, J. N., Fairbrother, N., & Joseph, K. S. (2023). Pregnancy-Specific Anxiety Tool (PSAT). The Journal of Clinical Psychiatry, 84(3). https://doi.org/10.4088/jcp.22m14696
Vancouver
Bayrampour H, Hohn RE, Tamana SK, Sawatzky R, Janssen PA, Bone JN, et al. Pregnancy-Specific Anxiety Tool (PSAT). The Journal of Clinical Psychiatry. 2023;84(3). doi:10.4088/jcp.22m14696
BibTeX
@article{Bayrampour2023,
author = {Bayrampour, Hamideh and Hohn, Richard E and Tamana, Sukhpreet K and Sawatzky, Richard and Janssen, Patricia A and Bone, Jeffrey N and Fairbrother, Nichole and Joseph, K S},
title = {Pregnancy-Specific Anxiety Tool (PSAT)},
journal = {The Journal of Clinical Psychiatry},
year = {2023},
volume = {84},
number = {3},
doi = {10.4088/jcp.22m14696}
}
EUVIMED